West Pharmaceutical Services Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital increased by 2409.8% to $102.90M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 103000.0%, from -$100.00K to $102.90M. This is a positive signal — higher values indicate stronger performance for this metric.
A positive value indicates cash generation through efficient working capital management, while a negative value indicates cash tied up in operations.
This metric aggregates changes in working capital components, such as accounts receivable, inventory, and accounts payab...
Highly comparable across all sectors; a key indicator of operational efficiency and cash conversion cycle health.
operating_increase_decrease_in_operating_capital| Q1 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q1 '26 | |
|---|---|---|---|---|---|
| Value | $34.60M | $100.00K | -$100.00K | $4.10M | $102.90M |
| QoQ Change | — | -99.7% | -200.0% | >999% | >999% |
| YoY Change | — | — | -100.3% | — | >999% |